Medhus Bio, Inc. is developing the following technologies:

 Easy-Western :

One step western-blot, dot-blot and immuno-blotting with color, fluorescent and luminescent options for detection.

 GFIA :

A novel, patent-pending immuno-assay superior to traditional ELISA with the added convenience of a homogenous format.

 Multi-Cart :

Paraplexed lateral-flow cartridges with chemi-luminescent detection for the diagnostic market.

 3-D Bioreactor :

A novel, patent-pending, turbulence-free bioreactor for stem cell growth and expansion.

 Assays for Stem Cell Differentiation :

Novel biochemical assays for assessing stem cell differentiation into hepatocytes, cardiomyocytes, neuronal cells, hematopoitic cells and pancreatic B cells.